Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
American Journal of Respiratory and Critical Care Medicine|February 8, 2012
Future directions in early cystic fibrosis lung disease research: an NHLBI workshop reportBonnie W Ramsey, Susan Banks-Schlegel, Frank J Accurso, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 1, 2020
The EXTrauterine Environment for Neonatal Development Supports Normal Intestinal Maturation and DevelopmentHeron D Baumgarten, Christina M Wright, Avery C Rossidis, et al.
American Journal of Audiology|September 22, 2021
Clinical Considerations for Routine Auditory and Vestibular Monitoring in Patients With Cystic FibrosisAngela C Garinis, Gayla L Poling, Ronald C Rubenstein, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2025
Dietary manipulation of intestinal microbes prolongs survival in a mouse model of Hirschsprung diseaseNaomi E Butler Tjaden, Megan J Liou, Sophie E Sax, et al.
The Lancet. Respiratory Medicine|February 26, 2023
Safety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trialsAhmet Z Uluer, Gordon MacGregor, Pilar Azevedo, et al.
Journal of the American Heart Association|February 15, 2023
Collagen-Specific HSP47+ Myofibroblasts and CD163+ Macrophages Identify Profibrotic Phenotypes in Deceased Hearts With SARS-CoV-2 InfectionsAndrii Puzyrenko, Elizabeth R Jacobs, Nathan Padilla, et al.
The New England Journal of Medicine|February 23, 2017
Assessing the Risks Associated with MRI in Patients with a Pacemaker or DefibrillatorRobert J Russo, Heather S Costa, Patricia D Silva, et al.
International Forum of Allergy & Rhinology|January 28, 2022
Cystic Fibrosis Foundation otolaryngology care multidisciplinary consensus recommendationsAdam J Kimple, Brent A Senior, Edward T Naureckas, et al.
The New England Journal of Medicine|November 19, 2010
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutationFrank J Accurso, Steven M Rowe, J P Clancy, et al.
Thorax|August 10, 2011
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutationJ P Clancy, Steven M Rowe, Frank J Accurso, et al.
Pageof 12